A new study reveals why cheaper versions of blockbuster biologic drugs often face delays, keeping costs high for patients ...

Each day, millions of people pick up a prescription drug from their local pharmacy or mailbox. Most are affordable, with ...

The Association for Accessible Medicines’ annual U.S. Generic & Biosimilar Medicines Savings Report, in partnership with the IQVIA Institute, reveals that the use of Food and Drug Administration ...

Replacing high-cost generics with cheaper medications that have the same clinical benefit could have cut down spending and saved patients about 88%, according to Johns Hopkins research published in ...

Reliable supply helps ensure patients aren’t caught in the middle. Generics account for more than 90% of prescriptions dispensed in the United States, making supply continuity essential to the entire ...

The particularly harsh winter across much of the country has made the last month particularly difficult for those who suffer from asthma. Exacerbating their distress is the fact that the price of ...

Switzerland’s Sandoz sees Canada and Brazil markets as testing grounds before semaglutide goes off patent in Europe and the U.S. in the 2030s.

In 2022 and 2023, there are a number of big therapies losing patent exclusivity, which opens the door to generics that could save as much as $30 billion. While knowing what drugs are under review the ...

The Supreme Court unanimously sided with generic drugmaker Hikma ( HKMPF) and against Amarin Corp. ( AMRN) in a case dealing ...

President Donald Trump announced that more than 600 generic medications have been added to the direct-to-consumer website.

Recent press reports and other evidence suggest that Medicare Part D plans may be encouraging the use of brand-name drugs instead of generics. However, the scope of such practices is unclear. We ...

UBS Virtual Generics and Biosimilars Day June 10, 2026 10:30 AM EDTCompany ParticipantsBalaji Prasad - Chief Strategy OfficerConference ...